novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Bioelectronic Medicine. Challenging the future

20 Setembro 2016

Maria Guarino
Research Associate Neuronal Control of Metabolic Disturbances
CEDOC | NOVA Medical School

Role of vitamin D deficiency in cardiovascular disease

20 Setembro 2016
0

Safety - the big challenge for oral anticoagulants

20 Setembro 2016
0

-->